Expect Some Stent Patients to Be Switched to Clopidogrel

November 2017

Questions are coming up about whether it's okay for patients to switch antiplatelet meds after a coronary stent.

Current guidelines prefer the combo of aspirin plus Brilinta (ticagrelor) or Effient (prasugrel) after an acute coronary syndrome...instead of aspirin plus clopidogrel.

Earlier studies suggest that Brilinta or Effient reduce CV risk more than clopidogrel...but they cause more bleeding and cost a lot more.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote